Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)

Market Cap	1.04B
Revenue (ttm)	111.75M
Net Income (ttm)	-59.17M
Shares Out	119.80M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,337
Open	8.70
Previous Close	8.70
Day's Range	8.60 - 8.80
52-Week Range	7.90 - 35.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It operates in Tablet, Capsule, Liquid, and Ointment segments. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, musculoskeletal, dermatological, anti-diabetic, and oral rehydration salt. Central Pharmaceuticals Ltd. was incorporated in 1980 and is headquartered in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 74
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: CENTRALPHL

Financial Performance

In 2023, Central Pharmaceuticals's revenue was 29.33 million, an increase of 12.81% compared to the previous year's 26.00 million. Losses were -43.96 million, -35.59% less than in 2022.